Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute (Q35602123)
Jump to navigation
Jump to search
scientific article published on 31 December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute |
scientific article published on 31 December 2014 |
Statements
1 reference
Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute (English)
1 reference
John D Hainsworth
1 reference
Dana S Thompson
1 reference
John A Bismayer
1 reference
Victor G Gian
1 reference
William M Merritt
1 reference
Robert C Whorf
1 reference
Lindsey H Finney
1 reference
B Stephens Dudley
1 reference
31 December 2014
1 reference
1 reference
4
1 reference
5
1 reference
673-681
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference